WallStreetZenWallStreetZen

NASDAQ: LEXX
Lexaria Bioscience Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lexaria Bioscience earnings were -$9.4M for the trailing 12 months ending Feb 28, 2025, with N/A growth year over year. The latest LEXX earnings report on Feb 28, 2025 announced Q1 2025 earnings of -$2.7M, up 0.4% from last quarter. For the last reported fiscal year 2024 ending Aug 31, 2024, LEXX reported annual earnings of -$5.8M, with -13% growth.

LEXX earnings history

Current Revenue
$525.9k
Current Earnings
-$9.4M
Current Profit Margin
-1,784.2%

LEXX Return on Equity

Current Company
-107%
Current Industry
16.8%
Current Market
25.1%
LEXX's Return on Equity (-107%)... subscribe to Premium to read more.
High Return on Equity Performance

LEXX undefined

Current Company
-100.5%
Current Industry
3.2%
LEXX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LEXX announces earnings.

LEXX undefined

Current Company
-136.88%
Current Industry
-42.4%
LEXX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LEXX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LEXX-$9.28M-$9.38MN/A-$0.59
VYNE-$39.83M-$39.83MN/A-$0.93
PYPD-$26.41M-$29.02M-97.54%$4.91
GDTC-$2.11M-$2.39MN/A-$0.20
DOMH-$14.21M-$14.70MN/A-$2.38
View Top Biotech Stocks

Lexaria Bioscience Earnings Reports & History FAQ

What were Lexaria Bioscience's earnings last quarter?

On LEXX's earnings call on Invalid Date, Lexaria Bioscience (NASDAQ: LEXX) reported Q1 2025 earnings per share (EPS) of -$0.15, up 150% year over year. Total LEXX earnings for the quarter were -$2.71 million. In the same quarter last year, Lexaria Bioscience's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Lexaria Bioscience stock.

Is Lexaria Bioscience profitable or losing money?

As of the last Lexaria Bioscience earnings report, Lexaria Bioscience is currently losing money. Lexaria Bioscience's net profit (also called net income) for the twelve months ending Feb 28, 2025 was -$9.38 million, a 72.5% increase year over year.

What was LEXX's earnings growth in the past year?

As of Lexaria Bioscience's earnings date in Invalid Date, Lexaria Bioscience's earnings has grown year over year. LEXX earnings in the past year totalled -$9.38 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.